5 Best One Dollar Stocks to Buy Now

2. Aligos Therapeutics, Inc. (NASDAQ:ALGS)

Number of Hedge Fund Holders: 15

Aligos Therapeutics, Inc. (NASDAQ:ALGS) is a clinical stage biopharmaceutical company that is working on treatments for unmet medical needs in viral infections and liver diseases. Aligos Therapeutics, Inc. (NASDAQ:ALGS) is up about 3.25% year to date through July 8. In May, Aligos Therapeutics, Inc. (NASDAQ:ALGS) posted Q1 results. GAAP EPS in the period came in at -$0.53, missing estimates by $0.05. Revenue in the quarter inched up 0.4% year over year to $2.58 million.

Insider Monkey’s database of 943 hedge funds shows that 15 funds had stakes in Aligos Therapeutics, Inc. (NASDAQ:ALGS) as of the end of the March quarter. The most notable hedge fund stakeholder of Aligos Therapeutics, Inc. (NASDAQ:ALGS) was Oleg Nodelman’s EcoR1 Capital which owns a $3.4 million stake in the company.